Efficacy and safety of concentration-controlled everolimus with reduced-dose ... 7thSpace Interactive (press release) All patients received basiliximab and corticosteroids. Key endpoints at month 12 were composite efficacy failure (treated biopsy-proven acute rejection, graft loss, death, or loss to follow-up) and renal function (estimated glomerular filtration rate ... |
